U.S. Markets closed

GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,615.00-10.00 (-0.62%)
At close: 4:35PM BST
Full screen
Previous Close1,625.00
Open1,628.00
Bid1,605.00 x 175400
Ask1,640.00 x 417900
Day's Range1,614.50 - 1,632.00
52 Week Range1,446.50 - 1,745.56
Volume5,575,729
Avg. Volume7,962,167
Market Cap78.9B
Beta1.23
PE Ratio (TTM)47.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.00 (4.66%)
Ex-Dividend Date2017-05-11
1y Target EstN/A
  • Zacks2 days ago

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

  • Reuters2 days ago

    GlaxoSmithKline's new CEO prepares to trim drug pipeline

    GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs. Despite her non-pharmaceutical background in consumer brands, Emma Walmsley sees improving drug research productivity as her top priority, and she wants Britain's biggest drugmaker to have fewer but potentially more lucrative new medicine launches in future.

  • These Non-Tech Firms Are Making Big Bets On Artificial Intelligence
    Investor's Business Daily3 days ago

    These Non-Tech Firms Are Making Big Bets On Artificial Intelligence

    Loup Ventures has compiled a portfolio of 17 publicly traded non-tech companies that are making investments in artificial intelligence to improve their businesses.